American Capital Advisory’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
American Capital Advisory's BMY Position: Q1 2026 in Review
American Capital Advisory increased its Bristol-Myers Squibb (BMY) stake by 1.2% in Q1 2026, buying an estimated $1.69K and bringing the position to 2,397 shares worth $145K. The position accounts for 0.06% of the portfolio, ranked #123.
American Capital Advisory first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. The position peaked at $559K in Q1 2024. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- American Capital Advisory held 2,397 shares of Bristol-Myers Squibb worth $145K as of Q1 2026.
- American Capital Advisory bought 29 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.69K.
- Bristol-Myers Squibb made up 0.06% of American Capital Advisory's portfolio in Q1 2026, its #123 holding.
- American Capital Advisory first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
- American Capital Advisory's Bristol-Myers Squibb position peaked at $559K in Q1 2024.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on American Capital Advisory's 13F filing for Q1 2026, filed 29 Apr 2026.